Advanced Biomed Inc. Common StockADVB · SEC Filings
1.05 MFloat
2.05Price
3.39 MMarket Cap
Financials
TYPE
HEADLINE
FILED AT
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
NT 10-K
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
NT 10-Q
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
News
TYPE
HEADLINE
FILED AT
8-K
Advanced Biomed Inc. Terminates $25 Million Purchase Agreement with Helena Global Investment Opportunities I Ltd.
8-K
Advanced Biomed Inc. Announces Results of 2026 Annual Meeting of Stockholders
8-K
Advanced Biomed Inc. to Sell Taiwan Subsidiary for $490,000
8-K
Advanced Biomed Inc. Announces Strategic Pivot to AI, Leadership Transition, and Acquisition of Acellent Technologies
8-K
Advanced Biomed Inc. Enters into $600,000 Loan Agreement
8-K
Advanced Biomed Inc. to Acquire Acellent Technologies (Hong Kong) Co. Limited
Prospectus
TYPE
HEADLINE
FILED AT
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]
424B4
Form 424B4 - Prospectus [Rule 424(b)(4)]
424B4
Form 424B4 - Prospectus [Rule 424(b)(4)]
Registrations
TYPE
HEADLINE
FILED AT
RW
Form RW - Registration Withdrawal Request
S-1
Helena SPA - Under the ELOC (Equity Line of Credit) Agreement with Helena, the price at which shares are sold is determined by the market price of the company's common stock at the time of sale. Specifically, the purchase price per share is equal to the lowest intraday sale price of the common stock during the three trading days commencing on the date of Helena's receipt of the common stock related to an advance. The amount of shares sold is determined by the company, subject to certain conditions such as market conditions, trading price, and ownership limitations. The company has discretion over the timing and amount of shares sold, but cannot exceed certain caps like the Exchange Cap, which limits Helena's ownership to 19.99% of the issued and outstanding common stock.
8-A12B
Form 8-A12B - Registration of securities [Section 12(b)]
FWP
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
